平衡液与0.9%生理盐水治疗儿童脓毒性休克的比较
这项在五个国家47个急诊科开展的实用临床试验,将疑似脓毒性休克且灌注异常的儿童随机分配接受平衡液或0.9%生理盐水复苏,主要结局为30天或出院时的主要不良肾脏事件。结果显示两组主要结局事件发生率无显著差异(3.4% vs 3.0%,差异0.4个百分点,95%CI -0.5至1.3,RR 1.10,95%CI 0.88至1.40,P=0.85),无医院自由日数中位数两组均为23天。
要点
- 儿童脓毒性休克复苏使用平衡液与0.9%生理盐水,主要不良肾脏事件无显著差异
- 平衡液组高氯血症发生率低于生理盐水组(31.4% vs 49.0%)
- 两组无医院自由日数中位数均为23天,其他安全性结局无差异
核心结论
- 儿童脓毒性休克液体复苏采用平衡液与0.9%生理盐水相比,死亡、新发肾脏替代治疗或持续性肾功能障碍的发生率无显著差异。
研究设计与样本
- 实用临床试验,在五个国家47个急诊科开展,纳入2个月至<18岁疑似脓毒性休克且灌注异常的患者。
- 随机分配接受平衡液或0.9%生理盐水复苏,最长48小时;9041例入组,平衡液组4235例和生理盐水组4247例纳入分析。
- 主要结局为入组后30天或出院时(以先发生者为准)的主要不良肾脏事件,即死亡、新发肾脏替代治疗或持续性肾功能障碍的复合终点。
主要发现
- 主要结局事件在平衡液组发生137例(3.4%),生理盐水组124例(3.0%),差异0.4个百分点(95%CI -0.5至1.3),风险比1.10(95%CI 0.88至1.40),P=0.85。
- 入组后28天内无医院自由日数中位数两组均为23天(四分位距19至25)。
- 高氯血症在平衡液组868例(31.4%)、生理盐水组1383例(49.0%);高钠血症分别为52例(1.8%)和89例(3.1%);高乳酸血症分别为260例(19.8%)和228例(16.7%)。
- 其他安全性结局或不良事件未见差异。
临床怎么用
- 儿童脓毒性休克的液体复苏中,平衡液与0.9%生理盐水在主要肾脏结局上等效,选择可基于其他临床因素考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether treatment with balanced crystalloid fluid leads to better outcomes than 0.9% saline in children treated for septic shock is debated. METHODS: In this pragmatic clinical trial conducted at 47 emergency departments in five countries, patients (2 months to <18 years of age) with suspected septic shock and abnormal perfusion were randomly assigned to receive fluid resuscitation with either balanced fluid or 0.9% saline for up to 48 hours. The primary outcome was a major adverse kidney event (a composite of death, new renal-replacement therapy, or persistent kidney dysfunction) at 30 days after enrollment or hospital discharge, whichever occurred first. RESULTS: Of 9041 enrolled patients, 277 (6.1%) in the balanced-fluid group and 282 (6.2%) in the 0.9%-saline group withdrew from the trial, leaving 4235 and 4247 patients, respectively, for analysis. A primary-outcome event occurred in 137 patients (3.4%) in the balanced-fluid group and in 124 (3.0%) in the 0.9%-saline group (difference, 0.4 percentage points; 95% confidence interval [CI], -0.5 to 1.3; risk ratio, 1.10; 95% CI, 0.88 to 1.40; P = 0.85). The median number of hospital-free days during 28 days after enrollment was 23 (interquartile range, 19 to 25) in both groups. Hyperchloremia occurred in 868 patients (31.4%) in the balanced-fluid group and in 1383 (49.0%) in the 0.9%-saline group; hypernatremia in 52 (1.8%) and 89 (3.1%), respectively; and hyperlactatemia in 260 (19.8%) and 228 (16.7%). No differences in other safety outcomes or adverse events were seen. CONCLUSIONS: Among children treated for septic shock, no significant difference was seen in the incidence of death, new renal-replacement therapy, or persistent kidney dysfunction when fluid resuscitation was administered with balanced fluid as compared with 0.9% saline. (Funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; PRoMPT BOLUS ClinicalTrials.gov number, NCT04102371.).
引用
- Balamuth F, Weiss SL, Long E, et al. Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock. N Engl J Med. 2026. PMID: 42028918. doi:10.1056/NEJMoa2601969
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。